Envisioning the Future of Ocular Therapeutics

Introduction
Our Visulex® drug delivery system uses an easy to administer scleral lens shaped eye
applicator worn for less than 10 minutes. One revolutionary aspect of Aciont's technology platform is the incorporation of a
novel sustained release methodology in our passive delivery applicator.
Thus, Visulex® mitigates problems of insufficient drug delivery, bleeding and pain as well as risks of retinal detachment and infection often associated with injections or other invasive systems. Our lens device allows for prolonged release of a drug formulation into the eye via good surface contact and stable positioning, which provides a small area of more highly concentrated drug to be delivered. |
